Disease | candidiasis |
Comorbidity | C0376545|hematologic malignancies |
Sentences | 2 |
PubMedID- 21625317 | In the last decades, the global epidemiological impact of invasive candidiasis (ic) in patients with hematologic malignancies (hm) and in hematopoietic stem cell transplant (hsct) recipients has decreased and the incidence of invasive aspergillosis exceeded that of candida infections. |
PubMedID- 25603977 | Voriconazole is effective in hematologic malignancies with invasive candidiasis and is also effective for anti-fungal prophylaxis in patients at high risk of invasive aspergillosis (lung and hematopoietic stem cell transplant recipients [16,17]. |
Page: 1